Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-12-01 to 2024-12-01.)
ArticleCitations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies189
Antimicrobial resistance in low- and middle-income countries: current status and future directions137
Calycosin: a Review of its Pharmacological Effects and Application Prospects79
Current and emerging strategies to combat antimalarial resistance64
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae55
CAR-T cell therapy and infection: a review55
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis51
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management50
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials49
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal44
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications42
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities39
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies37
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-237
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations36
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications33
Bacteria and fungi as major bio-sources to fabricate silver nanoparticles with antibacterial activities31
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy31
A review on favipiravir: the properties, function, and usefulness to treat COVID-1930
Dengue vaccine: an update30
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies28
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study28
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs27
Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan27
Therapeutic strategies to address monkeypox27
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis27
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria26
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV26
0.10802102088928